Bargaining Power of Buyers: High concentration of technology creates a dependency, but the fragmented nature of the farming community leads to collective resistance through legal challenges and public advocacy. The cost of switching back to conventional seeds is high due to specialized equipment and chemical regimes.
Threat of Substitutes: Conventional seeds and emerging CRISPR-based open-source traits pose a long-term threat. However, the current productivity gains of Monsanto traits (yield and weed control) remain the dominant market standard.
Barriers to Entry: Extremely high. The combination of regulatory approval costs (averaging 136 million USD per trait) and a massive patent thicket prevents smaller players from competing in the transgenic space.
| Option | Rationale | Trade-offs |
|---|---|---|
| Aggressive Enforcement (Status Quo) | Maximizes short-term revenue and deters IP theft. | High litigation costs and severe brand erosion. |
| Value-Share Royalty Model | Shifts cost from upfront fee to a percentage of realized yield gain. | Complex monitoring and delayed cash flow. |
| Collaborative Stewardship | Ends litigation against accidental contamination; focuses on large-scale commercial theft. | Potential for increased free-riding by smaller actors. |